Condition: Amputation of Upper Limb · Sponsor: Integrum
This non-interventional clinical investigation is initiated for the purpose of long-term Post-Market Clinical Follow-up (PMCF) and the follow-up time of patients is expected to span from 6 months to \>20 years in function. It will collect and evaluate clinical data on the safety and performance of the OPRA™ Implant System when used on transhumeral amputees and within the scope of the intended use.
This description comes directly from the study's public registry record.
Chief Medical Officer, MD · +46 706753499 · karin.ganlov@integrum.se
Head of Clinical Operations, M.Sc · +46766015026 · johan.blechert@integrum.se
Always discuss trial participation with your own doctor first.
| The Alfred Hospital | Melbourne, Victoria, Australia | Not Yet Recruiting |
| Medical University of Vienna Clinical laboratory for bionic limb reconstruction Währinger Gürtel 18-20 1090 Vienna, AUSTRIA | Vienna, Austria | Recruiting |
| University Hospital Ghent, UX Ghent | Ghent, Belgium | Not Yet Recruiting |
| Hannover Medical School | Hanover, Germany | Not Yet Recruiting |
| University Hospital Tübing | Tübingen, Germany | Not Yet Recruiting |
| University Medical Center Groningen | Groningen, Netherlands | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06753110